Publication | Closed Access

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

Clinical ImmunologyMedicineHuman RetrovirusImmunologyAntiviral ResponsePthr.hiva DnaT Cell ImmunityCd4 T Cell ResponsesCellular Immune ResponseHivMva.hiva VaccinesPrime-boost StrategyViral Immunity